These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 26519251)

  • 1. Case Report: Apixaban-Associated Gluteal Artery Extravasation Reversed With PCC3 Without FFP.
    Denetclaw TH; Tam J; Arias V; Kim R; Martin C
    J Pharm Pract; 2016 Aug; 29(4):427-30. PubMed ID: 26519251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Managing Nonoperable Intracranial Bleeding Associated With Apixaban: A Series of 2 Cases.
    Faust AC; Tran DM; Lo C; Lai S; Sheperd L; Liu M; Denetclaw T
    J Pharm Pract; 2018 Feb; 31(1):107-111. PubMed ID: 29278991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activated prothrombin complex concentrate to reverse the factor Xa inhibitor (apixaban) effect before emergency surgery: a case series.
    Schultz NH; Lundblad R; Holme PA
    J Med Case Rep; 2018 May; 12(1):138. PubMed ID: 29764497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Managing Subdural Bleeding Associated With Rivaroxaban: A Series of 3 Cases.
    Faust AC; Woodard S; Koehl JL; Mees W; Steinke D; Denetclaw TH
    J Pharm Pract; 2016 Jun; 29(3):257-62. PubMed ID: 26787638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prothrombin Complex Concentrate for Major Bleeding on Factor Xa Inhibitors: A Prospective Cohort Study.
    Schulman S; Gross PL; Ritchie B; Nahirniak S; Lin Y; Lieberman L; Carrier M; Crowther MA; Ghosh I; Lazo-Langner A; Zondag M;
    Thromb Haemost; 2018 May; 118(5):842-851. PubMed ID: 29564837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prothrombin Complex Concentrate before Urgent Surgery in Patients Treated with Rivaroxaban and Apixaban.
    Barzilai M; Kirgner I; Steimatzky A; Salzer Gotler D; Belnick Y; Shacham-Abulafia A; Avivi I; Raanani P; Yahalom V; Nakav S; Varon D; Yussim E; Bachar GN; Spectre G
    Acta Haematol; 2020; 143(3):266-271. PubMed ID: 31610537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Probable pulmonary embolism with repeat administration of prothrombin complex concentrate in a factor Xa inhibitor patient.
    King GS; Cottingham LG; Hughes RE; Ratliff PD
    J Clin Pharm Ther; 2018 Dec; 43(6):903-905. PubMed ID: 29885249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical outcomes and management associated with major bleeding in patients with atrial fibrillation treated with apixaban or warfarin: insights from the ARISTOTLE trial.
    Held C; Hylek EM; Alexander JH; Hanna M; Lopes RD; Wojdyla DM; Thomas L; Al-Khalidi H; Alings M; Xavier D; Ansell J; Goto S; Ruzyllo W; Rosenqvist M; Verheugt FW; Zhu J; Granger CB; Wallentin L
    Eur Heart J; 2015 May; 36(20):1264-72. PubMed ID: 25499871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apixaban-induced subdural bleeding: case presentation and literature review.
    Alayad E; Khairy S; Aloraidi A
    BMJ Case Rep; 2018 Mar; 2018():. PubMed ID: 29602894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-activated prothrombin complex concentrates for major bleeding in patients on apixaban and rivaroxaban.
    Sheikh-Taha M
    Intern Emerg Med; 2020 Sep; 15(6):1123-1124. PubMed ID: 31664661
    [No Abstract]   [Full Text] [Related]  

  • 11. Plasma Exchange for Urgent Apixaban Reversal in a Case of Hemorrhagic Tamponade after Pacemaker Implantation.
    Lam WW; Reyes MA; Seger JJ
    Tex Heart Inst J; 2015 Aug; 42(4):377-80. PubMed ID: 26413023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spontaneous Hemopericardium in a Patient Receiving Apixaban Therapy: First Case Report.
    Sigawy C; Apter S; Vine J; Grossman E
    Pharmacotherapy; 2015 Jul; 35(7):e115-7. PubMed ID: 26095120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Observational Study of the Factor Xa Inhibitors Rivaroxaban and Apixaban as Reported to Eight Poison Centers.
    Spiller HA; Mowry JB; Aleguas A; Griffith JR; Goetz R; Ryan ML; Bangh S; Klein-Schwartz W; Schaeffer S; Casavant MJ
    Ann Emerg Med; 2016 Feb; 67(2):189-95. PubMed ID: 26298448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Andexanet Alfa for the Reversal of Factor Xa Inhibitor Activity.
    Siegal DM; Curnutte JT; Connolly SJ; Lu G; Conley PB; Wiens BL; Mathur VS; Castillo J; Bronson MD; Leeds JM; Mar FA; Gold A; Crowther MA
    N Engl J Med; 2015 Dec; 373(25):2413-24. PubMed ID: 26559317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utilization of thromboelastography and a low molecular weight heparin anti-Xa assay for guidance in apixaban reversal: A case report.
    Gilbert BW; Adams TR; Reynolds TR; Moran DA; Philip GJ
    Am J Emerg Med; 2019 Oct; 37(10):1991.e1-1991.e3. PubMed ID: 31375354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spontaneous splenic rupture associated with apixaban: a case report.
    Lowry LE; Goldner JA
    J Med Case Rep; 2016 Aug; 10(1):217. PubMed ID: 27506776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apixaban-induced hepatotoxicity.
    Cordeanu M; Lambert A; Gaertner S; Nouri S; Mirea C; Alt-Tebacher M; Stephan D
    Int J Cardiol; 2016 Feb; 204():4-5. PubMed ID: 26649445
    [No Abstract]   [Full Text] [Related]  

  • 18. Embolic stroke during apixaban therapy for left atrial appendage thrombus.
    Ohyagi M; Nakamura K; Watanabe M; Fujigasaki H
    J Stroke Cerebrovasc Dis; 2015 Apr; 24(4):e101-2. PubMed ID: 25620711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of apixaban in the patients undergoing the ablation of atrial fibrillation.
    Nagao T; Inden Y; Shimano M; Fujita M; Yanagisawa S; Kato H; Ishikawa S; Miyoshi A; Okumura S; Ohguchi S; Yamamoto T; Yoshida N; Hirai M; Murohara T
    Pacing Clin Electrophysiol; 2015 Feb; 38(2):155-63. PubMed ID: 25487164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apixaban versus Antiplatelet drugs or no antithrombotic drugs after anticoagulation-associated intraCerebral HaEmorrhage in patients with Atrial Fibrillation (APACHE-AF): study protocol for a randomised controlled trial.
    van Nieuwenhuizen KM; van der Worp HB; Algra A; Kappelle LJ; Rinkel GJ; van Gelder IC; Schutgens RE; Klijn CJ;
    Trials; 2015 Sep; 16():393. PubMed ID: 26340977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.